Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × nedaplatin × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1

Status

Unknown 5 Recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Capecitabine 25 Oxaliplatin 21 Paclitaxel 20 Fluorouracil 17 Gemcitabine 16 Docetaxel 16 Cisplatin 16 Drug Therapy 15 Leucovorin 14 Carboplatin 14 Irinotecan 12 pembrolizumab 11 tislelizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Injections 9 Specimen Handling 7 Pemetrexed 7 toripalimab 6 Trastuzumab 6 Standard of Care 6 Radiotherapy, Intensity-Modulated 6 Radiation 6 Cyclophosphamide 6 Bevacizumab 6 sintilimab 5 atezolizumab 5 Temozolomide 5 Folfox protocol 5 Azacitidine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03503136 2018-05-11

NX-NPC

Sun Yat-sen University

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡